Loading viewer...
investor_presentation
Format: PDF investor_presentation
ACETO Corporation announced the acquisition of generic drug-related assets from Citron Pharma and Lucid Pharma on November 3, 2016. The presentation outlines the transaction details, pro forma FY2017 outlook, and financing strategy. This strategic acquisition expands ACETO's portfolio in the generic pharmaceutical sector.
investor_presentation
31 Pages
Tesla